PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Optimizing Care in GEP-NET: Are All Somatostatin Analogues Created Equal?
Visit https://www.peervoice.com/CMC860 to view the entire programme with slides. After completing “Optimizing Care in GEP-NET: Are All Somatostatin Analogues Created Equal?”, participants will be able to: Overview the key data on somatostatin analogues (SSAs) for the management of gastroenteropancreatic neuroendocrine tumours (GEP-NET); Differentiate between the SSAs for the management of GEP-NET; and Define how to select between SSAs based on patient and drug characteristic to optimize outcomes.